Premium Serums and Vaccines Private Limited

Premium Serums and Vaccines Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24110MH2009PTC189968 Incorporated 29 January 2009 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹67.25 Cr
▲ 28% YoY
Net profit · FY 2025
₹9.64 Cr
Net margin 14.3%
EBITDA · FY 2025
₹17.83 Cr
EBITDA margin 26.5%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹75.1 Cr
Secured borrowings
Company age
17 yrs
Est. 2009
Employees · EPFO
112
Provident fund records

About Premium Serums and Vaccines Private Limited

Data last updated:

Premium Serums and Vaccines Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2009PTC189968. Its GSTIN is 27AAFCP0651A1ZX (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Shyam Bhalchandra Dhawan and Girish Nathuram Kolwankar.

Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 406 B Wing Highway Rose Co – Op Hsg Society 92 Dixit Road Extn. Vile Parle (East), Mumbai, Maharashtra, India – 400057.

As per the financials filed for FY 2025, the company reported a revenue of ₹67.25 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹9.64 Cr (net margin 14.3%) and EBITDA of ₹17.83 Cr (EBITDA margin 26.5%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 23% over five years.

The company has about 112 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Premium Serums and Vaccines. As per MCA filings, the company has open charges of ₹75.1 Cr on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 1 case is pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹1.99 Cr; the latest was in March 2011. Its 5 peer companies in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Beloorbayir Biotech Limited with revenue of ₹67.42 Cr.

Premium Serums and Vaccines Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0141846). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website premiumserums.com.

Company details

CIN U24110MH2009PTC189968
Registration Number 189968
Incorporation Date 29 January 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-26-0141846

Recognitions & Rankings of Premium Serums and Vaccines

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-26-0141846

Contact details

Premium Serums and Vaccines Private Limited's registered office is in Mumbai, Maharashtra. Its website is premiumserums.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    406 B Wing Highway Rose Co – Op Hsg Society 92 Dixit Road Extn. Vile Parle (East), Mumbai, Maharashtra, India – 400057
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Premium Serums and Vaccines Private Limited, buy the company report.

Comprehensive company report
Premium Serums and Vaccines Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Premium Serums and Vaccines operates one associated brand: Premium Serums and Vaccines. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing of biological products, including equine immunoglobulins and antivenoms, for healthcare applications.premiumserums.com

Business activity

The main business activity of Premium Serums and Vaccines is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Premium Serums and Vaccines Private Limited, buy the company report.

Financials of Premium Serums and Vaccines Private Limited

FY 2025 filings available

Premium Serums and Vaccines Private Limited reported revenue of ₹67.25 Cr (up 28% YoY) for FY 2025.

Revenue · FY 2025
₹67.25 Cr ▲ 28%
Net profit · FY 2025
₹9.64 Cr margin 14.3%
EBITDA · FY 2025
₹17.83 Cr margin 26.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 36%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 64%
3 years · compounded
▲ 33%
5 years · compounded
▲ 43%

Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 28% growth in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹17.83 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹9.64 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin26.5%
Net Profit Margin14.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Premium Serums and Vaccines Private Limited, buy the company report.

Board of directors of Premium Serums and Vaccines Private Limited

Premium Serums and Vaccines has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shyam Bhalchandra DhawanDirector29 Jan 200917 Years 9 MonthsCurrent
Girish Nathuram KolwankarDirector29 Jan 200917 Years 9 MonthsCurrent

Peer comparison

Premium Serums and Vaccines Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Beloorbayir Biotech Limited₹67.42 Cr (FY 2021)-4.0%Bangalore, Karnataka, India
United Bioceuticals Private Limited₹67.35 Cr (FY 2024)31.0%New Delhi, Delhi, India
Samson Laboratories Private Limited₹67.3 Cr (FY 2025)13.0%Delhi, India
Premium Serums and Vaccines Private Limitedthis company₹67.25 Cr (FY 2025)₹9.64 Cr14.3%28.0%112Mumbai, Maharashtra, India
Pharmax India Private Limited₹66.65 Cr (FY 2024)2.0%Mumbai, Maharashtra, India
Merril Pharma Private Limited₹66.57 Cr (FY 2025)25.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Premium Serums and Vaccines Private Limited, buy the company report.

Auditor

Premium Serums and Vaccines Private Limited is audited by TEMBEY & MHATRE for the financial year 2023.

Auditor firmFinancial yearFirm registration number
TEMBEY & MHATREFY 2023116359W

Shareholding

The shareholding of Premium Serums and Vaccines Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Premium Serums and Vaccines Private Limited, buy the company report.

Charges & borrowings

Open charges
₹75.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹60.15 Cr
Bank of Maharashtra₹14.95 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Mar 2025101081774Others₹3 CrOpen
25 Mar 2025101080971Others₹10.67 CrOpen
16 Dec 2023100840859Others₹26 LakhOpen
13 Dec 2023100840858Others₹4.6 CrOpen
09 May 2023100736693Others₹10 LakhOpen

To see the full charge records of Premium Serums and Vaccines Private Limited, buy the company report.

Total charge records: 10 View all charges

Deals & funding

Premium Serums and Vaccines Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹1.99 Cr; the latest was in March 2011.

Total deals
1
Funding round
1
Disclosed funding
₹1.99 Cr

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2011Funding round₹1.99 CrInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Premium Serums and Vaccines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Premium Serums and Vaccines Private Limited has a workforce of 112 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
112
Active EPFO establishments
1
Employee growth
-3.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27112
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Premium Serums and Vaccines Private Limited, buy the company report.

GST

Premium Serums and Vaccines has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AAFCP0651A1ZXMaharashtraActive01 Jul 2017
36AAFCP0651A1ZYTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Premium Serums and Vaccines Private Limited, buy the company report.

Recent activity

Premium Serums and Vaccines Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Girish Nathuram Kolwankar was appointed as Director on 29 Jan 2009.

AGM
Premium Serums And Vaccines Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records.
Filing
Premium Serums And Vaccines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101081774 was registered on 26 Mar 2025.
Charges
A charge with Others amounted to Rs. 10.67 Cr with Charge ID 101080971 was registered on 25 Mar 2025.
Charges
A charge with Others amounted to Rs. 0.26 Cr with Charge ID 100840859 was registered on 16 Dec 2023.
Charges
A charge with Others amounted to Rs. 4.60 Cr with Charge ID 100840858 was registered on 13 Dec 2023.
Charges
A charge with Others amounted to Rs. 0.10 Cr with Charge ID 100736693 was registered on 09 May 2023.
Charges
A charge with Others amounted to Rs. 3.57 Cr with Charge ID 100368173 was registered on 16 Jun 2020.
Charges
A charge with Others amounted to Rs. 6.50 Cr with Charge ID 100186300 was registered on 16 Feb 2018.
Charges
A charge with Others of Rs. 31.45 Cr registered on 22 Sep 2015 with Charge ID 100036910 was modified on 16 Feb 2018.
Charges
A charge with Others amounted to Rs. 31.45 Cr with Charge ID 100036910 was registered on 22 Sep 2015.
Charges
A charge with Bank Of Maharashtra of Rs. 9.25 Cr registered on 26 Sep 2009 with Charge ID 10181574 was modified on 30 Jul 2014.

6 earlier events are in the company report.

Frequently asked questions

Premium Serums and Vaccines is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 2009 (17+ years old) and is registered under CIN U24110MH2009PTC189968.

Premium Serums and Vaccines has 2 current directors:

The latest financial statements of Premium Serums and Vaccines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Premium Serums and Vaccines is 27AAFCP0651A1ZX, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAFCP0651A1ZY (Telangana).

The CIN (Corporate Identification Number) of Premium Serums and Vaccines is U24110MH2009PTC189968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Premium Serums and Vaccines has 8 court cases on record: 4 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.

Premium Serums and Vaccines was incorporated on 29 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.

Premium Serums and Vaccines has 1 deal on record (1 funding round), with disclosed funding of ₹1.99 Cr; the latest was in March 2011.

The peers of Premium Serums and Vaccines by revenue are Beloorbayir Biotech Limited, United Bioceuticals Private Limited, Samson Laboratories Private Limited, Pharmax India Private Limited, Merril Pharma Private Limited, all in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Girish Nathuram Kolwankar was appointed as Director on 29 Jan 2009. Shyam Bhalchandra Dhawan was appointed as Director on 29 Jan 2009.

Yes, Premium Serums and Vaccines is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-26-0141846).